While obvious targeting methods include inhibiting the upstream targets of Oct4 such as WNT, AKT and TGFβ[100], a relatively newer proposed method would be to target specific miroRNAs (miRNA) responsible for regulating Oct4A expression in ovarian cancer progression and chemoresistance. The gene discussed is POU5F1; the disease is ovarian cancer.